
BioFlyte provides innovative aerosol mass spectrometers for protection against biological and chemical threats.
Founded with the mission to safeguard critical infrastructure and public health, BioFlyte specializes in innovative aerosol mass spectrometers designed to detect and identify biological and low-volatility chemical threats at the point of need. Their products are engineered to be both affordable and scalable, eliminating the dependency on expensive reagents and consumables. BioFlyte focuses on providing security solutions for various market segments, including public safety, military, and industrial sectors.
BioFlyte has attracted notable investors and industry experts who support its mission to revolutionize biothreat detection. The company has achieved significant milestones in developing fieldable technology that offers rapid, on-site threat identification. Its impact is evident in enhanced security measures for critical infrastructure and improved response times for biological threat detection, positioning BioFlyte as a key player in the biothreat security industry.

Zeteo Tech
zeteotech.com

Trace Matters
tracematters.com

Aerosol Devices
aerosoldevices.com

Evogen
evogen.com

Biota Technology
biota.com

BioLum Sciences
biolumsciences.com

Andson Biotech
andsonbiotech.com

Innovative Biosensors

The Public Health Company

BennuBio
bennubio.com

Adeptrix
adeptrix.com
Thermo Fisher th
thermofisher.com

Biomeme
bio-meme.com

Stemloop
stemloop.com

Fluent BioSciences
fluentbio.com
Companies similar to BioFlyte include Zeteo Tech, Trace Matters, Aerosol Devices and Evogen.
BioFlyte was founded in 2020.
BioFlyte's headquarters is located in Albuquerque, NM, US.
BioFlyte's most recent funding round was for $5.4M (USD) in August 2023.
As of Aug 10, 2023, BioFlyte has raised a total of $12.8M (USD).
BioFlyte has 39 employees as of Feb 5, 2024.